Select Publications
Conference Abstracts
2023, 'Outcomes for active surveillance are similar for men with favourable risk ISUP-2 to those with ISUP-1 prostate cancer: A pair matched cohort study', in Journal of Clinical Urology, WILEY, AUSTRALIA, Gold Coast, Vol. 129, pp. 42 - 43, presented at Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand, AUSTRALIA, Gold Coast, 25 June 2022 - 28 June 2022, http://dx.doi.org/10.1177/20514158231154702
,2022, 'Index tumour grade better predicts biochemical recurrence following radical prostatectomy', in BJU INTERNATIONAL, WILEY, AUSTRALIA, Gold Coast, Vol. 129, pp. 47 - 47, presented at Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand, AUSTRALIA, Gold Coast, 25 June 2022 - 28 June 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000808481200069&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Is a biopsy necessary before offering a radical prostatectomy in all men? An analysis of the PI-RADS 4 & 5 lesions from the PRIMARY trial', in BJU INTERNATIONAL, WILEY, AUSTRALIA, Gold Coast, Vol. 129, pp. 160 - 161, presented at Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand, AUSTRALIA, Gold Coast, 25 June 2022 - 28 June 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000808481200262&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, '3-year outcomes from the prospective 'MRIAS' trial: A novel active surveillance protocol which incorporates multiparametric MRI to reduce frequency of biopsy in men with prostate cancer', in EUROPEAN UROLOGY, ELSEVIER, Vol. 81, pp. S421 - S421, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000812320400271&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Diagnostic accuracy, concordance and certainty with 68Ga-PSMA-11 PET/MRI fusion compared to mpMRI and 68Ga-PSMA-11 PET/CT alone for prostate cancer diagnosis: A PRIMARY trial sub-study', in EUROPEAN UROLOGY, ELSEVIER, Vol. 81, pp. S1103 - S1104, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000812320401137&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Multicenter validation of the diagnostic accuracy of multiparametric magnetic resonance imaging to detect residual prostate cancer in the follow-up of focal therapy with irreversible electroporation', in EUROPEAN UROLOGY, ELSEVIER, Vol. 81, pp. S502 - S502, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000812320400322&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'External validation of a model predicting increase in Gleason grade for men on Active Surveillance in the GAP3 consortium database', in European Urology, Elsevier BV, Vol. 81, pp. S427 - S428, http://dx.doi.org/10.1016/s0302-2838(22)00363-3
,2020, '99m-technetium-labelled PSMA radioguided surgery for the intraoperative detection of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for prostate cancer: preliminary cases from the DETECT trial', in INTERNATIONAL JOURNAL OF UROLOGY, WILEY, Vol. 27, pp. 115 - 115, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000585265700282&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Can we rely on psa changes in active surveillance to predict pathological progression?', in INTERNATIONAL JOURNAL OF UROLOGY, WILEY, Vol. 27, pp. 89 - 90, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000585265700219&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Focal ablation of apical prostate cancer lesions with irreversible electroporation', in INTERNATIONAL JOURNAL OF UROLOGY, WILEY, Vol. 27, pp. 113 - 113, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000585265700275&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Pilot trial comparing the performance of 68Ga-PSMA-11 PET/CT to 18F-PSMA-1007 PET/CT in the detection of prostate cancer recurrence in men with rising PSA following radical prostatectomy', in INTERNATIONAL JOURNAL OF UROLOGY, WILEY, Vol. 27, pp. 112 - 112, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000585265700272&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Early Cases from the DETECT trial: Radioguided Surgery with Technetium99 m-labelled PSMA to aid Intraoperative Lymph Node Metastases Detection for Patients Undergoing Radical Prostatectomy and ePLND for Prostate Cancer', in BJU INTERNATIONAL, WILEY, AUSTRALIA, Sydney, Vol. 125, pp. 86 - 87, presented at 73rd Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand, AUSTRALIA, Sydney, 07 March 2020 - 10 March 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000518206100169&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Feasibility and Quality-of-Life (QoL) Following Focal Ablation of Apical Prostate Cancer Lesions with Irreversible Electroporation (IRE)', in BJU INTERNATIONAL, WILEY, AUSTRALIA, Sydney, Vol. 125, pp. 87 - 87, presented at 73rd Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand, AUSTRALIA, Sydney, 07 March 2020 - 10 March 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000518206100170&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Oncological outcomes in men on active surveillance with Gleason 3+4 prostate cancer', in BJU INTERNATIONAL, WILEY, AUSTRALIA, Sydney, Vol. 125, pp. 86 - 86, presented at 73rd Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand, AUSTRALIA, Sydney, 07 March 2020 - 10 March 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000518206100168&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'DIAGNOSTIC ACCURACY OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING TO DETECT RESIDUAL PROSTATE CANCER FOLLOWING FOCAL THERAPY WITH IRREVERSIBLE ELECTROPORATION', in JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, Vol. 201, pp. E1079 - E1079, presented at 114th Annual Meeting of the American-Urological-Association (AUA), IL, Chicago, 03 May 2019 - 06 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000473345203427&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'LAB TO LITHOTOMY - A HISTORY OF IRREVERSIBLE ELECTROPORATION FROM LABORATORY TECHNIQUE TO PROSTATE CANCER TREATMENT', in JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, Vol. 201, pp. E254 - E255, presented at 114th Annual Meeting of the American-Urological-Association (AUA), IL, Chicago, 03 May 2019 - 06 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000473345200555&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Salvage irreversible electroporation for locally recurrent prostate cancer after radiotherapy - oncologic and functional outcomes', in BJU INTERNATIONAL, WILEY, AUSTRALIA, Brisbane, Vol. 123, pp. 17 - 18, presented at Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, AUSTRALIA, Brisbane, 13 April 2019 - 16 April 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000464354600030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Update on 12-month biopsy proven oncological and functional outcomes of primary irreversible electroporation for localised prostate cancer', in BJU INTERNATIONAL, WILEY, AUSTRALIA, Brisbane, Vol. 123, pp. 17 - 17, presented at Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, AUSTRALIA, Brisbane, 13 April 2019 - 16 April 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000464354600029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'P53 as a Predictor of Clinical Outcome in Localised Prostate Cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 14, pp. 65 - 66, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000439493100038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'False positive intraprostatic lesions on 68 Ga Positron emission tomography in an intermediate prostate cancer cohort: description of a benign cystic cellular pattern with intense PSMA activity', in BJU INTERNATIONAL, WILEY, AUSTRALIA, Melbourne, Vol. 121, pp. 74 - 75, presented at 71st Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, AUSTRALIA, Melbourne, 24 February 2018 - 27 February 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000425625700159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'An analysis of multiple biomarkers to better predict prostate cancer metastasis and death after radical prostatectomy.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, CA, San Francisco, Vol. 36, presented at Genitourinary Cancers Symposium, CA, San Francisco, 08 February 2018 - 10 February 2018, http://dx.doi.org/10.1200/JCO.2018.36.6_suppl.54
,2018, 'P53 as a predictor of clinical outcome in localized prostate cancer.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, CA, San Francisco, Vol. 36, presented at Genitourinary Cancers Symposium, CA, San Francisco, 08 February 2018 - 10 February 2018, http://dx.doi.org/10.1200/JCO.2018.36.6_suppl.57
,2017, 'Robot-assisted salvage node dissection for oligometastatic nodal disease detected by 68gallium-PSMA PET/CT: a multicentre retrospective series', in BJU INTERNATIONAL, WILEY-BLACKWELL, Canberra, AUSTRALIA, Vol. 119, pp. 78 - 79, presented at 70th Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Canberra, AUSTRALIA, 24 February 2017 - 27 February 2017, http://dx.doi.org/10.1016/j.juro.2017.02.1661
,2015, 'Ten-year quality of life and psychological outcomes of men managed entirely with active surveillance: The NSW Prostate Cancer Care and Outcomes Study', in BJU INTERNATIONAL, WILEY-BLACKWELL, AUSTRALIA, Cairns, Vol. 116, pp. 23 - 23, presented at 2nd Prostate Cancer World Congress (PCWC), AUSTRALIA, Cairns, 17 August 2015 - 21 August 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000359254200066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'MP60-04 QUANTITATIVE ASSESSMENT OF T2-WEIGHTED MRI TO BETTER IDENTIFY PATIENTS WITH PROSTATE CANCER IN A SCREENING POPULATION', in Journal of Urology, Ovid Technologies (Wolters Kluwer Health), Vol. 193, http://dx.doi.org/10.1016/j.juro.2015.02.2206
,2015, 'PD46-08 PROSPECTIVE STUDY OF PRE-BIOPSY MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING (MPMRI) COMPARED TO TRANSPERINEAL TEMPLATE MAPPING BIOPSY (TTMB) FOR DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: IS IT ACCURATE ENOUGH TO GUIDE SELECTION OF MEN FOR BIOPSY?', in Journal of Urology, Ovid Technologies (Wolters Kluwer Health), Vol. 193, http://dx.doi.org/10.1016/j.juro.2015.02.2739
,